ALPHA TEKNOVA INC
TKNONASDAQTrading Snapshot
- Day Range
- $7.88 – $8.18
- 52-Week Range
- $1.91 – $9.48
- Volume (shares)
- 679,629
- Avg Volume (shares)
- —
- Shares Outstanding
- 53.7M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $41M
- Last Q Revenue
- $12M
- P/E Ratio
- -25.7
- P/S Ratio
- 9.9x
- EPS (TTM)
- $-0.31
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.3%
ALPHA TEKNOVA INC
TKNO
StockOtter · stockotter.spaceAbout ALPHA TEKNOVA INC
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells
We remain encouraged by the operational performance of the Micro cap companies held in portfolios. TWST shares surged as a strong fiscal 3Q highlighted accelerating demand across several of the company's end markets. TKN
Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?
Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vacci
Teknova Announces Pricing of $40 Million Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vacci
Teknova Announces Proposed Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vacci
Teknova Announces Preliminary Third Quarter Financial Results
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vacci